Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1999-03-02
2000-12-26
Jarvis, William R. A.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514415, A61K 3140, A61K 31405
Patent
active
061660620
ABSTRACT:
A lyophilized pharmaceutical composition is described which contains Sodium [[3-(2-amino-1,2-dioxoethyl)-2-ethyl-1-phenylmethyl)-1H-indol-4-yl]oxy]ace tate, a Solubilizer, and a Stabilizer. Such compositions are storage stable and readily dissolve in aqueous medium to give injectable solution for treatment of sepsis, etc.
REFERENCES:
patent: 5654326 (1997-08-01), Bach et al.
Dr. Fiedler, Lexikon Der Hilfsstoffe Fur Pharmazie, Kosmetik Und Angrenzende Gebiete, Bd. 1, pp. 309-311 (1989) Editio Cantor, Aulendorf, Germany (no translation).
Dr. Fiedler, Lexikon Der Hilfsstoffe Fur Pharmazie, Kosmetik Und Angrenzende Gebiete, Bd. 2, pp. 751-755 (1989) Editio Cantor, Aulendorf, Germany (no translation).
Confer William Lester
Tai Hideaki
Eli Lilly and Company
Jarvis William R. A.
Shionogi & Co. Ltd.
LandOfFree
Pharmaceutical compositions containing phospholipase inhibitor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical compositions containing phospholipase inhibitor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical compositions containing phospholipase inhibitor will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-995393